Is GENI a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Genius Sports (GENI) rests on The NFL contract and BetVision: Exclusivity on official NFL data is the single most valuable thing Genius owns, and the extension running through the 2029 season removes the near-term renewal cliff that hung over the story. The bear case rests on the dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable. Analysts covering it publish targets from $6.00 to $18.00 against a $8.38 price, so even the professionals disagree by 110% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Genius Sports Limited is a sports data and technology company incorporated in Guernsey, headquartered in London, and listed on the New York Stock Exchange since its 2021 SPAC combination. The model has three linked parts. It signs exclusive rights with leagues and federations to collect their official real-time data, it distributes that data plus trading and streaming products to regulated sportsbooks, and it supplies technology back to the leagues themselves, which is often how the rights get paid for. Its anchor asset is the NFL, where Genius is the exclusive distributor of official data feeds and operates BetVision, the low-latency watch-and-bet product embedded inside sportsbook apps. That partnership was extended and widened and now runs through the end of the 2029 NFL season, and it lets Genius monetise advertising inventory against the BetVision streams. Beyond the NFL, the rights portfolio spans several hundred competitions including English football and FIBA basketball. The 2026 picture is one of fast growth built partly on an acquisition. Second-quarter 2026 revenue was roughly $196 million, up about 65% from roughly $119 million a year earlier and ahead of the roughly $185 million the company had guided, with adjusted EBITDA of about $53 million against roughly $45 million guided. Betting revenue rose from about $92 million to about $117 million, while Media revenue jumped from about $27 million to about $78 million after the roughly $844 million purchase of Legend, a digital sports and gaming media network that owns Covers.com, Casino.org and Casino Guru, closed on 1 May 2026. Management raised full-year 2026 guidance to roughly $1.005 billion to $1.025 billion of revenue and roughly $285 million to $295 million of adjusted EBITDA, about a 28.6% margin at the midpoint. Reported results are a different story: the group net loss widened to roughly $55.5 million in the first quarter of 2026 from roughly $8.2 million a year earlier, and trailing free cash flow was only about $28 million. At roughly $8.38 a share and a roughly $2.33 billion market cap, the stock prices in the guided ramp rather than the reported loss.

The bull case: what would have to be true for $18.00

The most optimistic published target on GENI is $18.00, +114.8% from the $8.38 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. The NFL contract and BetVision.

Exclusivity on official NFL data is the single most valuable thing Genius owns, and the extension running through the 2029 season removes the near-term renewal cliff that hung over the story. BetVision turns that data relationship into a second revenue line, because Genius now streams live NFL games inside sportsbook apps and can place advertising against those streams. The economics improve as more of the NFL audience wagers in-play rather than pre-game, since in-play markets consume far more data per event.

2. Legend and the pivot into owned media.

The roughly $844 million Legend deal, funded with about $607 million cash, about $44 million in equity and about $202.5 million of contingent consideration, added Covers.com, Casino.org and Casino Guru to the group. Legend drew roughly 320 million annual visits from about 118 million unique visitors in 2025, which gives Genius an owned audience it can route to the same sportsbooks that already pay it for data. That took Media revenue from about $27 million to about $78 million in a single quarter and reshaped the revenue mix.

3. Operating leverage over fixed rights costs.

League rights are largely fixed annual commitments, so incremental revenue over the same contracts drops through at high margins. That is visible in guidance moving to a roughly 28.6% adjusted EBITDA margin at the midpoint of the 2026 range, up from a business that was near break-even on that measure a few years ago. The same leverage runs in reverse if betting volumes disappoint while rights costs stay contracted.

4. Regulated market expansion and in-play mix.

Genius earns more when more jurisdictions regulate sports betting and when bettors shift toward live, in-play markets that need official low-latency feeds. Growth therefore tracks both the US state-by-state map and the international regulated footprint rather than any single product launch. The counterweight is that some markets are raising betting taxes on operators, which pressures the customers who ultimately fund Genius.

The bear case: what would have to be true for $6.00

The most pessimistic published target is $6.00, -28.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Genius Sports is worth if the risks below bite instead of the drivers above.

The dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable. Customer concentration compounds it, because a handful of large sportsbooks generate a substantial share of Betting revenue and any one of them insourcing trading or data would be difficult to replace. Reported profitability remains negative and the first-quarter 2026 net loss of roughly $55.5 million widened materially year over year, so the equity story currently rests on adjusted EBITDA, a measure that excludes share-based compensation and acquisition costs. The Legend deal added cash outflow, contingent consideration tied to performance targets and integration work, and its affiliate sites depend on search traffic that a Google algorithm change can reduce without warning. Regulatory shifts, higher betting taxes on operators, and the growth of prediction-market exchanges that sit outside the traditional sportsbook customer base are all outside the company's control.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding GENI already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on GENI

20 analysts cover GENI, with an average target of $10.93 (+30.4% against $8.38) and a split of 17 buy, 3 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the GENI forecast and price target page.

How is GENI valued? (as of August 2026)

Price
$8.38
Market cap
$2.33B
Forward P/E
7.83
Price / book
3.28
Beta
1.88
52-week range
$3.83 to $13.73

Snapshot for GENI as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$790 million
  • Q2 2026 revenue: ~$196 million, up ~65% year over year and ahead of ~$185 million guided
  • Q2 2026 adjusted EBITDA: ~$53 million against ~$45 million guided
  • FY2026 guidance (raised): ~$1.005 billion to ~$1.025 billion revenue, ~$285 million to ~$295 million adjusted EBITDA (~28.6% margin at midpoint)
  • Free cash flow (TTM): ~$28 million (~$51 million operating cash flow less ~$23 million capex)
  • Market cap: ~$2.33 billion (stock ~$8.38)

At roughly $2.33 billion the market cap is about 2.9x trailing revenue and roughly 2.3x the midpoint of guided 2026 revenue, or about 8x guided adjusted EBITDA before adjusting for the debt raised to fund Legend. That is a growth multiple rather than a value one, and it is being paid on an adjusted figure while GAAP results are still loss-making. Figures are approximate and tied to the asOf date, so check live numbers and the latest 6-K before drawing conclusions.

How do you decide if GENI is a buy?

Rather than asking whether GENI is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold GENI indirectly through an index or sector ETF before adding more.

What would change your mind on GENI

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: The NFL contract and BetVision stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: the dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the GENI stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about GENI against your real portfolio and see your actual exposure before deciding.

Investing in Genius Sports with AI

Connect the broker you already use and ask Walnut's AI how GENI fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is GENI a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on The NFL contract and BetVision, with revenue (ttm) at ~$790 million. The bear case rests on the dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable. Analysts covering it are spread from $6.00 to $18.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell GENI?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $6.00, -28.4% from the $8.38 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for GENI?

+

The NFL contract and BetVision. Exclusivity on official NFL data is the single most valuable thing Genius owns, and the extension running through the 2029 season removes the near-term renewal cliff that hung over the story. The most optimistic analyst target on GENI is $18.00, +114.8% from the $8.38 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for GENI?

+

The dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable. Customer concentration compounds it, because a handful of large sportsbooks generate a substantial share of Betting revenue and any one of them insourcing trading or data would be difficult to replace. Reported profitability remains negative and the first-quarter 2026 net loss of roughly $55.5 million widened materially year over year, so the equity story currently rests on adjusted EBITDA, a measure that excludes share-based compensation and acquisition costs. The Legend deal added cash outflow, contingent consideration tied to performance targets and integration work, and its affiliate sites depend on search traffic that a Google algorithm change can reduce without warning. Regulatory shifts, higher betting taxes on operators, and the growth of prediction-market exchanges that sit outside the traditional sportsbook customer base are all outside the company's control. The most pessimistic published target is $6.00, -28.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Genius Sports do?

+

Licenses official league data, the NFL above all, and monetises it through sportsbooks and betting products such as BetVision.

What would have to change for GENI to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The NFL contract and BetVision) stalling in the reported numbers rather than in the narrative, the risk above (the dominant structural risk is rights renewal: Genius does not own the sports, it rents them, and every renewal is an auction that Sportradar and others can bid up until the contract stops being profitable) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Genius Sports actually do?

+

It signs exclusive agreements with leagues and federations to capture their official live data, then distributes that data along with trading, streaming and marketing products to regulated sportsbooks. It also supplies technology back to leagues, which is frequently part of how the data rights are paid for. Since the Legend acquisition it additionally operates its own sports and casino media sites.

Is Genius Sports profitable?

+

Not on a reported basis. Genius guides to roughly $285 million to $295 million of adjusted EBITDA for 2026, a margin near 28.6% at the midpoint, but the group net loss in the first quarter of 2026 was roughly $55.5 million against roughly $8.2 million a year earlier. Adjusted EBITDA strips out share-based compensation, amortisation and acquisition costs, so the gap between the two measures is large and worth reading in the filings.

What is the NFL deal and when does it expire?

+

Genius is the NFL's exclusive distributor of official data feeds to sportsbooks and operates BetVision, the low-latency watch-and-bet product inside betting apps. The partnership was extended and expanded and now runs through the end of the 2029 NFL season, with Genius able to monetise advertising inventory on the BetVision streams. It is the company's most important single contract and also its largest concentration risk.

Walnut is informational, not investment advice, and gives no verdict on GENI. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is GENI a Buy or a Sell? The Bull and Bear Case (2026) - Walnut AI Investing App